Eden Research (LON:EDEN) Issues Earnings Results

Eden Research (LON:EDEN) announced its earnings results on Wednesday. The company reported GBX (0.36) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.

Eden Research Stock Performance

Shares of LON:EDEN traded down GBX 0.16 during trading hours on Wednesday, hitting GBX 2.19. The stock had a trading volume of 777,955 shares, compared to its average volume of 585,411. The stock’s fifty day simple moving average is GBX 2.73 and its 200 day simple moving average is GBX 3.17. The firm has a market capitalization of £17.57 million, a price-to-earnings ratio of -4.93 and a beta of 1.57. The company has a debt-to-equity ratio of 1.43, a quick ratio of 2.42 and a current ratio of 2.25. Eden Research has a 1-year low of GBX 1.96 and a 1-year high of GBX 5.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.